M&T Bank Corp Sanofi Transaction History

M&T Bank Corp

$30.1 Billion
Q3 2024

A detailed history of M&T Bank Corp transactions in Sanofi stock. As of the latest transaction made, M&T Bank Corp holds 51,668 shares of SNY stock, worth $2.67 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

51,668

Previous 51,668 -0.0%

Holding current value

$2.67 Million

Previous $2.98 Million -0.0%

% of portfolio

0.01%

Previous 0.0%

31 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 15, 2024	BUY	$48.54 - $58.53 $2,475 - $2,985	51 Added 0.1%	51,668 $2.98 Million
Q2 2024 Jul 31, 2024	BUY	$45.39 - $50.36 $20,334 - $22,561	448 Added 0.88%	51,617 $2.5 Million
Q1 2024 May 07, 2024	BUY	$45.75 - $52.48 $165,294 - $189,610	3,613 Added 7.6%	51,169 $2.49 Million
Q4 2023 Feb 06, 2024	SELL	$43.13 - $54.79 $47,788 - $60,707	-1,108 Reduced 2.28%	47,556 $2.36 Million
Q3 2023 Nov 02, 2023	BUY	$50.95 - $55.2 $165,230 - $179,013	3,243 Added 7.14%	48,664 $2.61 Million
Q2 2023 Aug 09, 2023	BUY	$50.45 - $57.18 $28,806 - $32,649	571 Added 1.27%	45,421 $2.45 Million
Q1 2023 May 11, 2023	SELL	$45.86 - $54.45 $41,640 - $49,440	-908 Reduced 1.98%	44,850 $2.44 Million
Q4 2022 Feb 13, 2023	BUY	$38.86 - $48.55 $503,314 - $628,819	12,952 Added 39.48%	45,758 $2.22 Million
Q4 2022 Feb 13, 2023	SELL	$38.86 - $48.55 $834,129 - $1.04 Million	-21,465 Reduced 39.55%	32,806 $1.59 Million
Q3 2022 Nov 14, 2022	SELL	$37.22 - $100.5 $780,317 - $2.11 Million	-20,965 Reduced 27.87%	54,271 $2.04 Million
Q2 2022 Aug 05, 2022	BUY	$48.99 - $57.46 $325,881 - $382,223	6,652 Added 9.7%	75,236 $3.73 Million
Q1 2022 May 09, 2022	BUY	$48.48 - $53.65 $522,275 - $577,971	10,773 Added 18.63%	68,584 $3.52 Million
Q4 2021 Feb 07, 2022	SELL	$47.07 - $52.35 $897,295 - $997,948	-19,063 Reduced 24.8%	57,811 $2.9 Million
Q3 2021 Oct 28, 2021	SELL	$47.89 - $53.12 $297,253 - $329,715	-6,207 Reduced 7.47%	76,874 $3.71 Million
Q2 2021 Aug 13, 2021	SELL	$49.36 - $54.25 $274,737 - $301,955	-5,566 Reduced 6.28%	83,081 $4.37 Million
Q1 2021 May 06, 2021	SELL	$45.46 - $50.51 $543,337 - $603,695	-11,952 Reduced 11.88%	88,647 $4.38 Million
Q4 2020 Feb 12, 2021	SELL	$45.3 - $51.62 $83,895 - $95,600	-1,852 Reduced 1.81%	100,599 $4.89 Million
Q3 2020 Nov 06, 2020	SELL	$49.47 - $53.77 $82,812 - $90,010	-1,674 Reduced 1.61%	102,451 $5.14 Million
Q2 2020 Jul 29, 2020	SELL	$42.91 - $52.5 $924,624 - $1.13 Million	-21,548 Reduced 17.15%	104,125 $5.32 Million
Q1 2020 May 14, 2020	BUY	$38.02 - $51.66 $905,522 - $1.23 Million	23,817 Added 23.38%	125,673 $5.5 Million
Q4 2019 Feb 07, 2020	BUY	$44.25 - $50.86 $790,437 - $908,512	17,863 Added 21.27%	101,856 $5.11 Million
Q3 2019 Nov 12, 2019	SELL	$40.34 - $46.64 $194,196 - $224,524	-4,814 Reduced 5.42%	83,993 $3.89 Million
Q2 2019 Aug 12, 2019	SELL	$40.43 - $44.3 $610,776 - $669,240	-15,107 Reduced 14.54%	88,807 $3.84 Million
Q1 2019 May 15, 2019	BUY	$40.83 - $45.43 $135,433 - $150,691	3,317 Added 3.3%	103,914 $4.6 Million
Q4 2018 Feb 01, 2019	SELL	$41.48 - $45.59 $327,277 - $359,705	-7,890 Reduced 7.27%	100,597 $4.37 Million
Q3 2018 Nov 09, 2018	BUY	$40.0 - $44.84 $986,160 - $1.11 Million	24,654 Added 29.41%	108,487 $4.85 Million
Q2 2018 Aug 10, 2018	SELL	$37.63 - $41.22 $236,504 - $259,067	-6,285 Reduced 6.97%	83,833 $3.35 Million
Q1 2018 May 04, 2018	BUY	$38.98 - $45.76 $192,522 - $226,008	4,939 Added 5.8%	90,118 $3.61 Million
Q4 2017 Feb 06, 2018	SELL	$42.86 - $50.61 $548,522 - $647,706	-12,798 Reduced 13.06%	85,179 $3.66 Million
Q3 2017 Nov 13, 2017	SELL	$47.04 - $50.34 $42,147 - $45,104	-896 Reduced 0.91%	97,977 $4.88 Million
Q2 2017 Aug 11, 2017	BUY	N/A	98,873	98,873 $4.74 Million

Others Institutions Holding SNY

# of Institutions

810

Shares Held

268M

Call Options Held

Put Options Held

1.9M

View Full List

About Sanofi

Ticker SNY
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,508,100,096
Market Cap $130B
Description
Sanofi, together with its subsidiaries, engages in the research, development, manufacture, and marketing of therapeutic solutions in the United States, Europe, and internationally. It operates through three segments: Pharmaceuticals, Vaccines, and Consumer Healthcare. The company provides specialty care products, including human monoclonal antib...

More about SNY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of M&T Bank Corp, based on Form 13F filings with the SEC.

News

Stay updated on M&T Bank Corp with notifications on news.

Account